• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchLexeo Therapeutics
    Picture of Lexeo Therapeutics logo

    LXEO — Lexeo Therapeutics Share News

    $2.800.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    • Market Cap
      $229.86m
    • Enterprise Value
      $18.74m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • LXEO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    LXEO Dividends
    • Brief: Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020

      18/12/2023 12:40
    • U.S. STOCKS ON THE MOVE-Crocs, Avidity Biosciences, oil companies

      28/11/2023 18:55
    • U.S. STOCKS ON THE MOVE-Taboola, Cool Company, Twilio

      28/11/2023 16:00
    • U.S. STOCKS ON THE MOVE-Gold miners, Estee Lauder, Adobe

      28/11/2023 14:21
    • Lexeo Therapeutics rises as IPO research quiet period ends

      28/11/2023 13:51
    • Biotech Lexeo Therapeutics stumbles in weak Nasdaq debut

      03/11/2023 16:43
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.